Regulation of the Expression of Inducible Nitric Oxide Synthase
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378859005 | ||
| 003 | CHVBK | ||
| 005 | 20180305123341.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20031107xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/BC.2003.152 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/BC.2003.152 | ||
| 245 | 0 | 0 | |a Regulation of the Expression of Inducible Nitric Oxide Synthase |h [Elektronische Daten] |c [H. Kleinert, P. M. Schwarz, U. Förstermann] |
| 520 | 3 | |a Nitric oxide (NO), generated by the inducible isoform of nitric oxide synthase (iNOS), has been described to have beneficial microbicidal, antiviral, antiparasital, immunomodulatory, and antitumoral effects. However, aberrant iNOS induction at the wrong place or at the wrong time has detrimental consequences and seems to be involved in the pathophysiology of several human diseases. iNOS is primarily regulated at the expression level by transcriptional and posttranscriptional mechanisms. iNOS expression can be induced in many cell types with suitable agents such as bacterial lipopolysaccharides (LPS), cytokines, and other compounds. Pathways resulting in the induction of iNOS expression may vary in different cells or different species. Activation of the transcription factors NF-κB and STAT-1α, and thereby activation of the iNOS promoter, seems to be an essential step for iNOS induction in most cells. However, at least in the human system, also post-transcriptional mechanism are critically involved in the regulation of iNOS expression. The induction of iNOS can be inhibited by a wide variety of immunomodulatory compounds acting at the transcriptional levels and/or post-transcriptionally. | |
| 540 | |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Biochemistry |2 nationallicence | |
| 690 | 7 | |a Molecular biology |2 nationallicence | |
| 690 | 7 | |a Cellular biology |2 nationallicence | |
| 700 | 1 | |a Kleinert |D H. |4 aut | |
| 700 | 1 | |a Schwarz |D P. M. |4 aut | |
| 700 | 1 | |a Förstermann |D U. |4 aut | |
| 773 | 0 | |t Biological Chemistry |d Walter de Gruyter |g 384/10-11(2003-11-07), 1343-1364 |x 1431-6730 |q 384:10-11<1343 |1 2003 |2 384 |o bchm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/BC.2003.152 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/BC.2003.152 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kleinert |D H. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Schwarz |D P. M. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Förstermann |D U. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Biological Chemistry |d Walter de Gruyter |g 384/10-11(2003-11-07), 1343-1364 |x 1431-6730 |q 384:10-11<1343 |1 2003 |2 384 |o bchm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||